ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

University of Pittsburgh at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

University of Pittsburgh takes part in 3 sessions at ESMO 2026 in Madrid. Its work examines treatment approaches and outcomes in lung, ovarian and small-cell lung cancers, including how insulin resistance relates to immunotherapy outcomes and antibody-drug conjugate strategies.

OrganizationESMO 2026 Attendance
University & institute
Public research university in Pittsburgh, Pennsylvania, with a school of medicine.
Poster
Mon Oct 26
12:00–12:45
Impact of insulin resistance on immunotherapy outcomes in patients with stage IV non-small cell lung cancer
Monday Poster Display session 6
Lung & thoracic cancers
Poster
Mon Oct 26
12:00–12:45
Satellite
Mon Oct 26
13:25–13:55
Emerging Targets and Developments with Antibody-Drug Conjugates (ADCs) for ES-SCLC
Daiichi Sankyo and MSD - Shaping the Future of ES-SCLC: Pioneering Treatment Strategies
Lung & thoracic cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Pittsburgh

Tell us what you sell and we’ll find the people at University of Pittsburgh most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction